Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricVRTXVertex PharmaceuticalsGILDGilead SciencesREGNRegeneron Pharmaceuticals
Snapshot
Price$554.15$149.70$849.21
Market cap$115.02B$162.98B$68.59B
Valuation
P/E28.7x20x20.1x
Forward P/E27x14.3x19.2x
Growth
Revenue growth10.1%3.5%5.9%
EPS growth6.1%55.5%4.4%
Profitability
Net margin35.5%31.0%29.6%
ROE23.9%42.2%14.3%
Balance sheet & cash
Debt / equity0.01x1.1x0.09x
Free cash flow yield3.1%5.2%6.3%
Dividend yield—2.6%0.6%
Verdict
Investment ratingFavorable· 67Strong· 74Favorable· 69

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearVRTXtoday $554GILDtoday $150REGNtoday $849
2027$441.05 – $646.87+17% CAGR$174.58 – $256.05+71% CAGR$664.93 – $975.23+15% CAGR
2028$468.04 – $686.46+11% CAGR$271.45 – $398.12+63% CAGR$694.19 – $1,018.14+9% CAGR
2029$496.68 – $728.47+10% CAGR$422.08 – $619.04+61% CAGR$724.73 – $1,062.94+8% CAGR
2030$527.08 – $773.05+9% CAGR$656.29 – $962.55+59% CAGR$756.62 – $1,109.71+7% CAGR
2031$559.34 – $820.36+8% CAGR$1,020.46 – $1,496.67+58% CAGR$789.91 – $1,158.54+6% CAGR
5-yr CAGR0.2% – 8.2%46.8% – 58.5%-1.4% – 6.4%